Renate Haselmann

450 total citations
9 papers, 352 citations indexed

About

Renate Haselmann is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Renate Haselmann has authored 9 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Renate Haselmann's work include Glioma Diagnosis and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Renate Haselmann is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Renate Haselmann collaborates with scholars based in Germany. Renate Haselmann's co-authors include Jürgen Debus, Stephanie E. Combs, Lutz Edler, Daniel Habermehl, Oliver Jäkel, Andreas Unterberg, Stefan Rieken, Thomas Haberer, Wolfgang Wick and S. Heeger and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and BMC Cancer.

In The Last Decade

Renate Haselmann

9 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renate Haselmann Germany	7	212	148	93	86	80	9	352
Alessandra Mirri Italy	9	159 0.8×	111 0.8×	76 0.8×	45 0.5×	65 0.8×	15	307
Fred Hsu Canada	11	300 1.4×	150 1.0×	159 1.7×	59 0.7×	70 0.9×	22	433
Masakazu Ogura Japan	11	174 0.8×	70 0.5×	102 1.1×	86 1.0×	58 0.7×	29	368
M Weil United States	12	260 1.2×	162 1.1×	80 0.9×	97 1.1×	184 2.3×	39	520
M. Soike United States	14	258 1.2×	115 0.8×	133 1.4×	128 1.5×	130 1.6×	52	469
J.P. Bahary Canada	11	202 1.0×	184 1.2×	57 0.6×	64 0.7×	53 0.7×	21	388
Petr Burkoň Czechia	10	224 1.1×	178 1.2×	87 0.9×	67 0.8×	55 0.7×	35	348
Anca‐L. Grosu Germany	12	153 0.7×	72 0.5×	77 0.8×	127 1.5×	35 0.4×	28	389
Russell Fuhrer United States	11	212 1.0×	146 1.0×	100 1.1×	62 0.7×	71 0.9×	29	375
F. Meacci Italy	7	145 0.7×	86 0.6×	93 1.0×	82 1.0×	97 1.2×	19	354

Countries citing papers authored by Renate Haselmann

Since Specialization

Citations

This map shows the geographic impact of Renate Haselmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate Haselmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate Haselmann more than expected).

Fields of papers citing papers by Renate Haselmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renate Haselmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate Haselmann. The network helps show where Renate Haselmann may publish in the future.

Co-authorship network of co-authors of Renate Haselmann

This figure shows the co-authorship network connecting the top 25 collaborators of Renate Haselmann. A scholar is included among the top collaborators of Renate Haselmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renate Haselmann. Renate Haselmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hauswald, Henrik, Alexandra D Jensen, Juergen Krauss, et al.. (2018). Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx. Clinical and Translational Radiation Oncology. 13. 64–73. 4 indexed citations

Combs, Stephanie E., Daniel Habermehl, Meinhard Kieser, et al.. (2013). Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial. BMC Cancer. 13(1). 419–419. 21 indexed citations

Jensen, Alexandra D, Marc Münter, Helge Bischoff, et al.. (2011). Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity‐modulated RT radiotherapy and cetuximab. Cancer. 117(13). 2986–2994. 49 indexed citations

Combs, Stephanie E., Iris Burkholder, Lutz Edler, et al.. (2010). Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial. BMC Cancer. 10(1). 533–533. 59 indexed citations

Combs, Stephanie E., Meinhard Kieser, Stefan Rieken, et al.. (2010). Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial. BMC Cancer. 10(1). 478–478. 73 indexed citations

Combs, Stephanie E., Lutz Edler, Iris Burkholder, et al.. (2010). Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial. BMC Cancer. 10(1). 40 indexed citations

Jensen, Alexandra D, Marc Münter, Helge Bischoff, et al.. (2007). IMRT and cetuximab in stage 3 non-small cell lung cancer: The NEAR trial (NCT00115518). Journal of Clinical Oncology. 25(18_suppl). 18168–18168. 2 indexed citations

Bischoff, Helge, Renate Haselmann, Carmen Timke, et al.. (2006). Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518). BMC Cancer. 6(1). 122–122. 27 indexed citations

Combs, Stephanie E., S. Heeger, Renate Haselmann, et al.. (2006). Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol. BMC Cancer. 6(1). 133–133. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact